Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-29 6:59 pm Purchase | 2025-09-22 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | 683 Capital Management, LLC | 5,435,000 5.360% | 5,435,000 (New Position) | Filing History |
| 2025-09-24 4:33 pm Purchase | 2025-09-22 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | Bhat Laxminarayan | 3,680,874 3.800% | 68,490 (+1.90%) | Filing History |
| 2025-09-24 4:30 pm Unchanged | 2025-09-22 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | Parag Saxena | 6,259,806 6.200% | 0 (Unchanged) | Filing History |
| 2025-08-14 4:15 pm Sale | 2025-06-30 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | TANG CAPITAL MANAGEMENT, LLC | 3,399,975 4.800% | -510,329 (-13.05%) | Filing History |
| 2025-08-14 4:08 pm Purchase | 2025-06-30 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 8,000,000 9.900% | 8,000,000 (New Position) | Filing History |
| 2025-08-14 2:01 pm Sale | 2025-06-30 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | CVI Investments, Inc. | 3,571,603 4.900% | -428,397 (-10.71%) | Filing History |
| 2025-07-01 6:40 pm Sale | 2025-06-27 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | Parag Saxena | 6,259,806 8.700% | -9,100 (-0.15%) | Filing History |
| 2025-07-01 4:30 pm Purchase | 2025-06-27 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | Bhat Laxminarayan | 3,612,384 5.200% | 414,142 (+12.95%) | Filing History |
| 2025-07-01 10:18 am Purchase | 2025-06-26 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | CVI Investments, Inc. | 4,000,000 5.900% | 1,553,624 (+63.51%) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | TANG CAPITAL MANAGEMENT, LLC | 3,910,304 7.800% | 3,910,304 (New Position) | Filing History |
| 2025-02-14 4:16 pm Sale | 2024-12-31 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | Schonfeld Strategic Advisors LLC | 1,314,915 2.820% | -457,800 (-25.82%) | Filing History |
| 2025-02-07 4:10 pm Sale | 2024-12-31 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | CVI Investments, Inc. | 2,446,376 4.900% | -886,956 (-26.61%) | Filing History |
| 2025-01-31 9:31 pm Purchase | 2024-12-18 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | Parag Saxena | 6,268,906 12.400% | 17,300 (+0.28%) | Filing History |
| 2024-12-23 11:30 am Purchase | 2024-12-16 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | CVI Investments, Inc. | 3,333,332 7.200% | 3,333,332 (New Position) | Filing History |
| 2024-12-20 4:30 pm Purchase | 2024-12-18 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | Bhat Laxminarayan | 3,198,242 6.800% | 304,328 (+10.52%) | Filing History |
| 2024-11-14 5:16 pm Purchase | 2024-09-30 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | Armistice Capital, LLC | 3,357,953 9.990% | 1,593,953 (+90.36%) | Filing History |
| 2024-11-14 4:15 pm Purchase | 2024-09-30 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | Schonfeld Strategic Advisors LLC | 1,772,715 5.300% | 1,772,715 (New Position) | Filing History |
| 2024-08-23 4:07 pm Purchase | 2024-08-22 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | Parag Saxena | 6,251,606 16.900% | 6,251,606 (New Position) | Filing History |
| 2024-08-23 4:06 pm Purchase | 2024-08-22 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | Bhat Laxminarayan | 2,893,914 8.600% | 8,236 (+0.29%) | Filing History |
| 2024-08-14 4:07 pm Purchase | 2024-08-06 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | Integrated Core Strategies (US) LLC | 1,563,595 5.200% | 1,563,595 (New Position) | Filing History |